Analgesia and haloperidol: a hypothesis

Area of Science:

• Pharmacology
• Pain Management
• Oncology

Background:

• Previous case reports suggest Haloperidol can reduce narcotic analgesic requirements in intractable pain syndromes.
• Haloperidol's potential analgesic properties warrant further investigation, particularly in cancer pain management.

Purpose of the Study:

• To evaluate Haloperidol as an adjunctive treatment for intractable cancer pain in a controlled, double-blind study.
• To explore the relationship between Haloperidol, Meperidine, and opiate receptor activity.

Main Methods:

• Conducting a controlled double-blind evaluation of Haloperidol.
• Analyzing dose-response relationships between Haloperidol and analgesic effects.
• Reviewing clinical literature on Haloperidol for narcotic addiction withdrawal and maintenance.

Main Results:

• Previous observations indicate Haloperidol can significantly reduce or eliminate the need for narcotic analgesics.
• The study aims to confirm these findings in a rigorous clinical trial setting.

Conclusions:

• Haloperidol shows promise as an adjunctive therapy for intractable cancer pain.
• Further research is needed to elucidate the mechanisms underlying Haloperidol's analgesic effects, including its relationship to opiate receptors and structural similarities to Meperidine.